Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer.

BMC cancer - 2 Aug 2024

Liu Renyu, Yang Ting, Huang Jinyu, Xiao Zicheng, Liu Jinhui, Li Zhenghao, Tong Shiyu

Abstract excerpt

BACKGROUND: Although immunotherapy shows tremendous potential in the treatment of bladder cancer (BLCA), the overall prognosis and response rates to immunotherapy in BLCA remain suboptimal. METHODS: We performed an extensive evaluation of glycosyltransferase expression patterns in BLCA patients by analyzing 210 glycosyltransferase-related genes. Subsequently, we established correlations between these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Regulation, Neoplastic
Share to Glycosyltransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Lymphocytes, Tumor-Infiltrating

Share to Nomograms

Share to Risk Assessment

Share to Tumor Microenvironment

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39095785
DOI: 10.1186/s12885-024-12712-w
PMCID: PMC11297740

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer.PMID 39095785Read ↗

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)Semantic proximity Read ↗

New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity Read ↗

An IFN-γ-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohortsSemantic proximity Read ↗

Correlation between the immune microenvironment and bladder cancer based on a prognostic miRNA risk modelSemantic proximity Read ↗

Lactylation Modification as a Promoter of Bladder Cancer: Insights from Multi-Omics AnalysisSemantic proximity Read ↗

Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancerSemantic proximity Read ↗

Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancerSemantic proximity Read ↗

Targeting Macrophage-Associated Core Genes for Prognostic Prediction and Therapeutic Insights in Bladder CancerSemantic proximity Read ↗

Exploring prognostic DNA methylation genes in bladder cancer: a comprehensive analysisSemantic proximity Read ↗

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer.Semantic proximity Read ↗

Three Conserved Immune Dysfunction and Exclusion Subtypes in Bladder and Pan-cancers: Prognostic and Immunotherapeutic SignificanceSemantic proximity Read ↗

Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.